Fortress Biotech: Momentum Meets Bargain Value
Discover why Fortress Biotech's stock is a smart choice for investors seeking both momentum and value in today's market.
- Latest
- Trending
Discover why Fortress Biotech's stock is a smart choice for investors seeking both momentum and value in today's market.
Chinese banks reduce Russian transactions fearing U.S. dollar access loss. The move aims to avoid global financial isolation.
Explore why Bitcoin's funding rate is positive despite bearish trends on Binance. Discover implications for crypto markets.
Bitcoin sees sharp decline, influenced by technical resistance and market reactions to Nvidia's earnings.
Uniswap and Across introduce ERC-7683 to address liquidity fragmentation in Ethereum's DeFi ecosystem.
Okta boosts annual guidance after Q2 results beat estimates, driven by new business gains, lifting shares by over 4%.
Innovative ThermoLoop™ technology by NewHydrogen aims to reduce green hydrogen costs, collaborating with UC Santa Barbara.
Polygon's MATIC falls 10.64% to $0.44, amid increased trading volume and high volatility.
Brazil created 188,021 formal jobs in July, surpassing last year's figures, signaling a job market recovery.
Oil prices dip due to weaker crude demand and slight US inventory decline, signaling end of summer travel season.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.